View in EDS

An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity.

Saved in:
Bibliographic Details
Title: An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity.
Authors: McClary WD; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Brandt DS; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Jennewein MF; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Singh J; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Beaver S; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Ykema MR; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Press C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Melief E; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Bakken J; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Fusco P; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Lo E; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Battisti P; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Cross N; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Kasal DN; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Hartwig AT; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Casper C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Gerhardt A; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Voigt EA; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA. Electronic address: voigte@ohsu.edu.
Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Sep 10; Vol. 385, pp. 114054. Date of Electronic Publication: 2025 Jul 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-4995
DOI:10.1016/j.jconrel.2025.114054